{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:54:57Z","timestamp":1772819697539,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1016\/s0165-0327(99)00187-1","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T20:57:15Z","timestamp":1027630635000},"page":"119-126","source":"Crossref","is-referenced-by-count":12,"title":["A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression"],"prefix":"10.1016","volume":"61","author":[{"given":"J.P","family":"Feighner","sequence":"first","affiliation":[]},{"given":"R.H","family":"Ehrensing","sequence":"additional","affiliation":[]},{"given":"A.J","family":"Kastin","sequence":"additional","affiliation":[]},{"given":"B.E","family":"Leonard","sequence":"additional","affiliation":[]},{"given":"L","family":"Sverdlov","sequence":"additional","affiliation":[]},{"given":"G","family":"Nicolau","sequence":"additional","affiliation":[]},{"given":"A","family":"Patel","sequence":"additional","affiliation":[]},{"given":"J","family":"Hlavka","sequence":"additional","affiliation":[]},{"given":"H","family":"Abajian","sequence":"additional","affiliation":[]},{"given":"J.F","family":"Noble","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0165-0327(99)00187-1_BIB1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/ajp.135.5.562","article-title":"Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-1) in depression","volume":"135","author":"Ehrensing","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0165-0327(99)00187-1_BIB2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-0327(94)90098-1","article-title":"Improvement in major depression after low subcutaneous doses of MIF-1","volume":"31","author":"Ehrensing","year":"1994","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 6","key":"10.1016\/S0165-0327(99)00187-1_BIB3","first-page":"32","article-title":"Efficacy issues with antidepressants","volume":"58","author":"Fawcett","year":"1997","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB4","first-page":"1314","volume":"Vol. 22(12)","author":"Hlavka","year":"1997"},{"key":"10.1016\/S0165-0327(99)00187-1_BIB5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(78)90051-5","article-title":"Enkephalin and other peptides reduce passiveness","volume":"9","author":"Kastin","year":"1978","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0091-3057(81)90066-6","article-title":"Effects of MIF-1 and three related peptides on reserpine-induced hypothermia in mice","volume":"15","author":"Kastin","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB7","doi-asserted-by":"crossref","unstructured":"Kelly, J.P., Nicolau, G., Noble, J., Molinar, R., Leonard, B.E., 1998. Acute in vivo interactions of INN 00835 with psychoprobes in the rat. 2000 (manuscript in preparation).","DOI":"10.1016\/S0924-977X(98)80212-5"},{"issue":"2\u20133","key":"10.1016\/S0165-0327(99)00187-1_BIB8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-0327(99)00018-X","article-title":"The effect of treatment with a new antidepressant: INN 00835 on platelet serotonin uptake in depressed patients","volume":"55","author":"Kelly","year":"1999","journal-title":"J. Affect. Disord."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00004714-199408000-00002","article-title":"Tricyclic antidepressant concentrations in plasma: An estimate of their sensitivity and specificity as a predictor of response","volume":"14","author":"Perry","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0091-3057(89)90027-0","article-title":"MIF-1 is active in a chronic stress animal model of depression","volume":"32","author":"Pignatiello","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB11","article-title":"Automated on-line SPE\/LC\/MS quantitation of INN 00835, a synthetic pentapeptide, in human plasma","author":"Plante","year":"1998"},{"issue":"Suppl. 6","key":"10.1016\/S0165-0327(99)00187-1_BIB12","first-page":"40","article-title":"Development of new antidepressants","volume":"58","author":"Sambunaris","year":"1997","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB13","first-page":"590","article-title":"FASTCLUS procedure to identify subtypes within a study population following treatment with a new antidepressant drug","author":"Sverdlov","year":"1998"},{"key":"10.1016\/S0165-0327(99)00187-1_BIB14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00433040","article-title":"Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression","volume":"65","author":"Tuomisto","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0165-0327(99)00187-1_BIB15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(83)90136-5","article-title":"Rapid clinical effectiveness of MIF-1 in the treatment of major depressive illness","volume":"4","author":"van der Velde","year":"1983","journal-title":"Peptides"},{"key":"10.1016\/S0165-0327(99)00187-1_BIB16","series-title":"Psychopharmacology of Anxiolytics and Antidepressants","first-page":"231","author":"Van Riesen","year":"1991"},{"key":"10.1016\/S0165-0327(99)00187-1_BIB17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0163-7258(90)90076-E","article-title":"Animal models of depression: An overview","volume":"45","author":"Wilner","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/S0165-0327(99)00187-1_BIB18","first-page":"587","article-title":"Mechanism of action of l-prolyl-l-leucyl-glycinamide and its effect on Parkinson\u2019s disease","author":"Xu","year":"1986"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032799001871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032799001871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T22:50:20Z","timestamp":1555800620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032799001871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S0165032799001871"],"URL":"https:\/\/doi.org\/10.1016\/s0165-0327(99)00187-1","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}